PubRank

T Cooke

Author PubWeight™ 65.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres. J Pathol 2003 3.14
2 A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. Br J Surg 1985 2.66
3 Birthweight specific trends in cerebral palsy. Arch Dis Child 1990 2.56
4 Trends in birth prevalence of cerebral palsy. Arch Dis Child 1987 2.34
5 Oestrogen receptors and survival in early breast cancer. Br Med J (Clin Res Ed) 1981 2.14
6 Epidemiology of cerebral palsy in England and Scotland, 1984-9. Arch Dis Child Fetal Neonatal Ed 1998 2.01
7 Oestrogen receptors and prognosis in early breast cancer. Lancet 1979 1.83
8 Life expectancy in children with cerebral palsy. BMJ 1994 1.72
9 Lipoprotein(a) in cirrhosis. BMJ 1992 1.63
10 Metal-responsive elements act as positive modulators of human metallothionein-IIA enhancer activity. Mol Cell Biol 1987 1.62
11 The changing epidemiology of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 1996 1.60
12 Recommendations for HER2 testing in the UK. J Clin Pathol 2000 1.41
13 Effects of birth weight, gestational age, and maternal obstetric history on birth prevalence of cerebral palsy. Arch Dis Child 1987 1.37
14 The long term prognostic significance of c-erbB-2 in primary breast cancer. Br J Cancer 1991 1.35
15 Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease. Br J Cancer 1982 1.19
16 Cerebral palsy and multiple births. Arch Dis Child Fetal Neonatal Ed 1996 1.15
17 Advanced-stage cervix cancer: rapid tumour growth rather than late diagnosis. Br J Cancer 2000 1.14
18 Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients. Br J Cancer 2008 1.09
19 Detection of early neoplastic changes in experimentally induced colorectal cancer using scanning electron microscopy and cell kinetic studies. Gut 1984 1.09
20 C-erbB-2 gene amplification: a molecular marker in recurrent bladder tumors? Cancer Res 1995 1.06
21 Patient acceptance of day surgery. Ann R Coll Surg Engl 1994 1.04
22 Possible test for selection of adjuvant systemic therapy in early cancer of the breast. Br J Surg 1980 0.99
23 Assessment of HER2 status in breast cancer: why, when and how? Eur J Cancer 2000 0.99
24 The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast. Br J Cancer 1991 0.93
25 The effects of intracolonic EGF on mucosal growth and experimental carcinogenesis. Br J Cancer 1991 0.91
26 Prostatic carcinoma cell DNA content measured by flow cytometry and its relation to clinical outcome. Br J Surg 1986 0.90
27 Assessment of a scoring scheme for the preoperative diagnosis of breast lumps. Ann R Coll Surg Engl 1984 0.88
28 The clinical application of oestrogen receptor analysis in early cancer of the breast. Ann R Coll Surg Engl 1982 0.87
29 The effect of pharmacological supplementation with vitamin C on low-density lipoprotein oxidation. Br J Clin Pharmacol 1997 0.83
30 Importance of cellular DNA content in pre-malignant breast disease and pre-invasive carcinoma of the female breast. Br J Surg 1987 0.83
31 Contamination of operating room personnel during total arthroplasty. Clin Orthop Relat Res 1991 0.83
32 Effect of anxiety on the rate of gastric emptying of liquids. Br J Anaesth 1998 0.83
33 Rising to the challenges of achieving day surgery targets. Anaesthesia 2006 0.82
34 Delayed postoperative gastric emptying following intrathecal morphine and intrathecal bupivacaine. Can J Anaesth 1999 0.82
35 Advanced life support: role of the rural registered nurse. Aust J Rural Health 1996 0.82
36 Prognostic value of nucleolar organizer regions and ploidy values in advanced colorectal cancer. Br J Surg 1989 0.82
37 Prevention of doxorubicin-induced alopedia by scalp hypothermia: relation to degree of cooling. Br Med J (Clin Res Ed) 1982 0.82
38 Human chorionic gonadotrophin expression in colorectal adenocarcinoma. Dis Colon Rectum 1986 0.81
39 Bile acid receptors in colorectal cancer. Br J Surg 1983 0.80
40 Cholesterol and lipoprotein (a) levels in psoriasis. Ir Med J 1995 0.80
41 Acquired cerebral palsy. Arch Dis Child 1989 0.80
42 Enteroglucagon and experimental intestinal carcinogenesis in the rat. Gut 1987 0.79
43 Effect of warfarin on cell kinetics, epithelial morphology and tumour incidence in induced colorectal cancer in the rat. Gut 1985 0.79
44 Predictive power of progesterone receptor status in early breast carcinoma. Br J Surg 1987 0.79
45 Management of screen detected ductal carcinoma in situ of the female breast. Br J Surg 1989 0.79
46 Lipoprotein [Lp(a)] and peripheral vascular disease. J Intern Med 1992 0.78
47 4-Chlorobenzyl sulfonamide and sulfamide derivatives of histamine homologues: the design of potent histamine H3 receptor antagonists. Bioorg Med Chem Lett 1999 0.78
48 Prolonged access to the venous system using the Hickman right atrial catheter. Ann R Coll Surg Engl 1983 0.77
49 Lipoprotein(a) and treatment of chronic renal disease. J Intern Med 1993 0.77
50 Vitamin E supplementation in hyperlipidaemic patients: effect of increasing doses on in vitro and in vivo low-density lipoprotein oxidation. Eur J Clin Invest 1999 0.77
51 Experimental colonic carcinogenesis: changes in faecal bile acids after promotion of intestinal tumours by small bowel resection in the rat. Gut 1988 0.76
52 Effect of menopause on low-density lipoprotein oxidation: is oestrogen an important determinant? Maturitas 2000 0.76
53 Evaluation of standard haemodynamic tests of autonomic function and HbA1c as predictors of delayed gastric emptying in patients with type 1 diabetes mellitus. Eur J Anaesthesiol 2000 0.75
54 Oestrogen receptors and survival in early breast cancer. Br Med J (Clin Res Ed) 1982 0.75
55 Ploidy studies in adenomatous polyps of the colon. J Clin Pathol 1986 0.75
56 Prevention of doxorubicin-induced alopecia. Br Med J (Clin Res Ed) 1981 0.75
57 Endocrine function and immunity. Br Med J (Clin Res Ed) 1981 0.75
58 A comparison of 10 MHz ultrasound and 201-thallium/99m-technetium subtraction scanning in primary hyperparathyroidism. Postgrad Med J 1993 0.75
59 Increasing hepatic arterial flow to hypovascular hepatic tumours using degradable starch microspheres. Br J Cancer 1996 0.75
60 Combined oestrogen-progestogen replacement therapy does not inhibit low-density lipoprotein oxidation in postmenopausal women. Br J Clin Pharmacol 1999 0.75
61 Changes in crypt cell DNA content during experimental colonic carcinogenesis. Br J Cancer 1986 0.75
62 Respect for the quality of life. Hosp Prog 1972 0.75
63 The use of tumour markers in clinical practice. Baillieres Clin Gastroenterol 1989 0.75
64 Chemotherapy in breast cancer. Lancet 1981 0.75
65 A microsurgical technique for the creation of arteriovenous fistulas. Br J Surg 1978 0.75
66 Estrogen receptors in early breast cancer. Eur J Cancer 1980 0.75
67 Kinetic changes in experimental colonic urinary diversion. Br J Surg 1987 0.75
68 Epidermal growth factor receptors. Br J Surg 1985 0.75
69 Growth inhibition of gastric cancer cell lines by the tyrphostin RG13022 and its effects on intracellular signalling. Int J Oncol 1996 0.75
70 Infusion cholecystography. Br J Surg 1985 0.75
71 Alteration in colonic epithelial cell DNA associated with intestinal neoplasia: selection of high risk patients. Br J Surg 1987 0.75
72 Integrating GB and US census microdata for studying the impact of family migration on partnered women's labour market status. Int J Popul Geogr 1999 0.75
73 Proliferation patterns and aneuploidy in adenomatous polyps of the colon. Br J Surg 1988 0.75
74 Direct coronal section CT of the retroperitoneum: normal anatomy without contrast. J Comput Tomogr 1981 0.75
75 Effect of a long-acting analogue of somatostatin, SMS 201-995, on the development of intestinal tumours in azoxymethane-treated rats. Carcinogenesis 1987 0.75